Endo Int'l (NASDAQ: ENDP) announced it completed the acquisition of Grupo Farmaceutico Somar, a leading, privately owned specialty pharmaceuticals company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE